GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Gencurix 229000.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Gencurix — daily KRX:229000

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Gencurix on TradingView ↗

About Gencurix

Its shares trade on KOSDAQ under the ticker 229000.KQ. It has been listed since 27 October 2015. In the fiscal year to 31 December 2025, it reported revenue of ₩7.55bn and a net loss of ₩7.39bn. At that date it held total assets of ₩32.11bn and shareholders' equity of ₩16.37bn.

Gencurix, Inc. is engaged in developing and manufacturing of cancer diagnostic test kits. The company is headquartered in Seoul, Seoul. The company went IPO on 2015-10-27. In addition, the Company is involved in the manufacturing and sale of breast cancer test (BCT) kits, Korean genetic polymorphism diagnostic kits, lung cancer and colorectal cancer diagnostic kits. The BCT kits are used for analyzing the expression level of the cancer-related gene. The products are sold under the name of GenesWell.

Figures and description from our data supplier, not checked against the company's own report.

More about Gencurix →

Latest on Gencurix

Our reporting

We have not reported on Gencurix yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Gencurix's ticker?

Gencurix trades as 229000.KQ on KOSDAQ, under ISIN KR7229000005.

What was Gencurix's last closing price?

We have not recorded a close for this listing yet. The chart above carries pricing from TradingView.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.